NASDAQ · Biotechnology

LSTA (LSTA) Stock

$1.44 -13.77% NASDAQ: LSTA Healthcare

Valuation

MetricValue
Price$1.44
Market Cap$13.11M
P/E Ratio-1.66
P/B Ratio1.93
P/S Ratio170.34
EPS (TTM)$-1.91
52-Week High$5.07
52-Week Low$1.44
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-113.33%
ROA-94.44%
ROCE-120.00%
Gross Margin98.82%
Operating Margin-101.78%
Net Margin-96.18%
Debt/Equity0.00
Current Ratio6.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$1.0M$0
Operating Profit$-29.0M$-58.0M$-26.0M$-22.0M$-18.0M
Net Profit$-27.0M$-54.0M$-21.0M$-20.0M$-17.0M
EPS$-7.45$-10.47$-2.58$-2.40$-1.91
Op Margin———-2240.9%-10711.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$97.0M$73.0M$55.0M$35.0M$18.0M
Total Liabilities$5.0M$7.0M$7.0M$6.0M$3.0M
Cash$25.0M$32.0M$23.0M$16.0M$16.0M
Borrowings$1.0M$0$0$0$0

Latest News

Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share Proactive · Jun 10, 2026 Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc. GlobeNewswire · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-22.0M$-21.0M$-20.0M$-19.0M$-16.0M
Investing Cash Flow$-55.0M$29.0M$10.0M$13.0M$15.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$8.0M$8.0M$-10.0M$-6.0M$0
Free Cash Flow$-22.0M$-21.0M$-20.0M$-19.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-47.16%
Quick Ratio4.23
Interest Coverage—
Return 1Y38.15%
Return 3Y0.54%
Return 5Y-82.24%

Ownership

Insiders Held20.89%
Institutions Held11.43%
Institutions Float Held14.44%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC271,8152026-03-31
Renaissance Technologies, LLC131,7152026-03-31
Deltec Asset Management LLC90,0002026-03-31
Rangeley Capital, LLC75,0002026-03-31
Geode Capital Management, LLC70,8872026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CLGN $0.27 -9.04% -0.48 $3.54M 0.00%
CLSDClearside Biomedical, Inc. $0.41 +0.00% -0.11 $2.15M 0.00%
ENLV $2.12 -5.36% 0.03 $35.68M 0.00%
KLTOKlotho Neurosciences, Inc. $0.38 -7.10% -1.13 $20.08M 0.00%

About LSTA

LSTA is led by CEO David J. Mazzo, employs 26 people, headquartered in US, publicly traded since 1999.

LSTA stock trades at $1.44 with a market capitalization of $13.11M. The stock is valued at a price-to-earnings (P/E) ratio of -1.66, price-to-book of 1.93, price-to-sales of 170.34. Over the past 52 weeks the stock has ranged between $1.44 and $5.07, and currently trades 71.6% below its 52-week high.

On profitability, LSTA generates a return on equity (ROE) of -113.33%, return on capital employed of -120.00%, an operating margin of -101.78%, a net profit margin of -96.18%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides